As of Nov 17
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 1.75, with a high estimate of 1.75 and a low estimate of 1.75. The median estimate represents a -1.13% decrease from the last price of 1.77.
The current consensus among 1 polled investment analysts is to Hold stock in Ocera Therapeutics Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.